Please use this identifier to cite or link to this item: http://hdl.handle.net/2445/210010
Title: Do ART and chemsex drugs get along? Potential drug-drug Interactions in a cohort of people living with HIV who engaged in chemsex: a retrospective observational study. 
Author: De la Mora, Lorena
Nebot, María J.
Martínez Rebollar, María
Lazzari, Elisa de
Tuset Creus, Montserrat
Laguno Centeno, Montserrat
Ambrosioni, Juan
Miquel, Laia
Blanch, Jordi
Ugarte, Ainoa
Torres, Berta
González, Ana
Inciarte Portillo, Alexy
Chivite, Ivan
Short, Duncan
Salgado García, Emilio José
Martinez, Esteban
Blanco, José L.
Mallolas Masferrer, Josep
Keywords: VIH (Virus)
Antiretrovirals
Interaccions dels medicaments
Drogues
Sexualitat
HIV (Viruses)
Antiretroviral agents
Drug interactions
Drugs of abuse
Sex
Issue Date: 1-Dec-2022
Publisher: Springer Nature
Abstract: Introduction: People living with HIV (PLWH) who engaged in chemsex are at risk of potential drug-drug interactions (pDDIs) with recreational drugs. This study aimed to characterize pDDIs between antiretroviral treatment (ART) and chemsex drugs and evaluate their association with unscheduled relevant hospital consultations. Methods: We conducted a single-center, retrospective, observational study in a series of gay, bisexual, and other men who have sex with men (gbMSM) living with HIV who engaged in chemsex and who attended a tertiary hospital in Barcelona, Spain, from February 2018 through August 2019. Associations between all recorded pDDIs and relevant unscheduled consultations were estimated using the incidence rate (IR) per 100 person-years of those events compared between patients with no pDDI (green flag) or moderate severity pDDI (orange flag) with patients with high severity pDDI (red flag) using the incidence rate ratio (IRR). Results: Among 172 PLWH engaged in chemsex, 249 ART regimens were prescribed: 44% based on integrase inhibitors, 30% on boosted ART, and 26% based on non-nucleoside reverse transcriptase inhibitors. The substances and recreational drugs most frequently used were erectile dysfunction agents (83%), methamphetamine (79%), GHB (77%), and alkyl nitrites (71%). Polydrug use was reported in 52%. We observed 2048 pDDIs. Of these, 23% were orange flag pDDIs; 88% related to boosted ARTs. The IR of the 285 unscheduled relevant episodes in patients with orange flag pDDIs was 64.67 (95% CI 40.07-89.28). The IRR of green flag pDDIs was 1.05 (95% CI 0.60-1.8; p = 0.876). Conclusion: One in four pDDIs were of moderate severity but no significant increase in the incidence of unscheduled relevant consultations was observed. A high number of unscheduled consultations, predominantly for psychiatric events and intoxication, were observed. Beyond using non-boosted ART to minimize pDDIs, other factors related to the practice of chemsex must be addressed, in order to offer a better approach.
Note: Reproducció del document publicat a: https://doi.org/DOI: 10.1007/s40121-022-00694-w
It is part of: Infectious Diseases and Therapy, 2022, vol. 11, num.6, p. 2111-2124
URI: http://hdl.handle.net/2445/210010
Related resource: https://doi.org/DOI: 10.1007/s40121-022-00694-w
ISSN: 2193-8229
Appears in Collections:Articles publicats en revistes (Medicina)
Articles publicats en revistes (IDIBAPS: Institut d'investigacions Biomèdiques August Pi i Sunyer)

Files in This Item:
File Description SizeFormat 
839062.pdf943.35 kBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons